Obama's new budget proposes historic, direct drug price negotiations in Medicare
Healthcare Dive - February 2, 2015
President Barack Obama on Monday unveiled a $4 trillion budget proposal which includes a provision seeking to grant the Secretary of Health and Human Services (HHS) the authority to negotiate high-cost drug prices covered under Medicare Part D insurance plans "to ensure access to and affordability of these treatments."
Biosimilar Drugs Promise to Cut Patient Costs, But Will Doctors and Insurers Buy Them?
International Business Times - January 23, 2015
The U.S. Food & Drug Administration is on track to approve a new drug by Sandoz, marking the first time a so-called biosimilar has made it through the agency’s accelerated approval process.
West Africa: Hepatitis C more prevalent than HIV/AIDS or Ebola yet lacks equal attention
ScienceDaily - February 4, 2015
Hepatitis C is more prevalent than HIV/AIDS or Ebola in parts of Africa, yet lacks equal attention, researchers say.
Pharmacist Provider Status Bill Reintroduced in Congress
Pharmacy Times - January 28, 2015
Pharmacists are getting closer to obtaining provider status, as federal legislation that would enable pharmacists to provide health care services to Medicare patients in underserved communities has been reintroduced in the US Senate and House of Representatives.
Adults forgo medication to save money
Managed Healthcare Executive - January 30, 2015
To save money, almost 8% of U.S. adults did not take their medication as prescribed, according to a National Center for Health Statistics report.
What will the new federal budget mean for pharmaceutical R&D tax credits?
BioPharma Dive - February 1, 2015
Innovation is a key "nutrient" for the good health and optimal growth of the biopharmaceutical industry. But, obviously, pharma is not the only industry that thrives on innovation.
Study supports Roche's disputed blockbuster flu drug Tamiflu
Reuters - January 30, 2015
A major analysis of one of the world's most fiercely disputed medicines, Roche's Tamiflu, has found it cuts flu symptoms by a day and can help some patients avoid hospital treatment and complications.
HHS announces historic changes to Medicare
Managed Healthcare Executive - January 28, 2015
Measurable goals and a timeline to move the Medicare program towards a value versus volume reimbursement model is being called a “transformative shift” that could redefine how care should be provided, measured and rewarded.
Scientists home in on reasons behind cancer drug trial disappointment
ScienceDaily - January 30, 2015
Scientists have discovered a 'hidden' mechanism which could explain why some cancer therapies which aim to block tumor blood vessel growth are failing cancer trials.
Battle Over Medicare Part D Rebates Begins Ahead of Obama Budget
Wall Street Journal - January 28, 2015
Nearly 400 organizations, including a coalition whose members include the pharmaceutical industry and insurers, have written an open letter to the U.S. House of Representatives to warn against forcing drug makers to give Medicare rebates to low-income beneficiaries.
Some Seeking Insurance Told They Didn’t Qualify, Others Balked At Cost, Poll Finds
Kaiser Health News - January 29, 2015
Nearly half of Americans lacking health insurance during the first year of the health law’s marketplaces appeared to be eligible for government assistance, but two-thirds of them said they found the health plans too expensive or were told they didn’t qualify, according to a survey released Thursday.
Contact,
Jan Tankersley
Senior Vice President, Marketing & Sales
Pharmaceutical Strategies Group (PSG)
Office: 972-943-7141
Email: JTankersley@PSGConsults.com
PSGNewsletter@PSGConsults.com
www.PSGConsults.com
 |
 |
 |